Related references
Note: Only part of the references are listed.Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data
Priscila H. Goncalves et al.
CANCER (2016)
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases A Randomized Clinical Trial
Paul D. Brown et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study
Sai-Hong Ignatius Ou et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
NCCN Guidelines Update: Breast Cancer
William Gradishar et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers
Anna S. Berghoff et al.
ESMO OPEN (2016)
Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases
Daniel B. Costa et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Testicular Cancer, Version 2.2015
Robert J. Motzer et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)
Targeted Therapies in Brain Metastases
Nancy U. Lin
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2014)
Cancer-Specific Outcomes Among Young Adults Without Health Insurance
Ayal A. Aizer et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Disparities in Stage at Diagnosis, Treatment, and Survival in Nonelderly Adult Patients With Cancer According to Insurance Status
Gary V. Walker et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The association between insurance status and prostate cancer outcomes: implications for the Affordable Care Act
B. A. Mahal et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2014)
New Pathologic Classification of Lung Cancer: Relevance for Clinical Practice and Clinical Trials
William D. Travis et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results
Riccardo Soffietti et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Marital Status and Survival in Patients With Cancer
Ayal A. Aizer et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01)
Bernhard C. Pestalozzi et al.
LANCET ONCOLOGY (2013)
Clinicopathologic Features, Patterns of Recurrence, and Survival Among Women With Triple-Negative Breast Cancer in the National Comprehensive Cancer Network
Nancy U. Lin et al.
CANCER (2012)
Epidemiology of Brain Metastases
Lakshmi Nayak et al.
CURRENT ONCOLOGY REPORTS (2012)
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
Martin Kocher et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis
Giuseppe Minniti et al.
RADIATION ONCOLOGY (2011)
Metastatic Behavior of Breast Cancer Subtypes
Hagen Kennecke et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
Eric L. Chang et al.
LANCET ONCOLOGY (2009)
Sites of Distant Recurrence and Clinical Outcomes in Patients With Metastatic Triple-negative Breast Cancer High Incidence of Central Nervous System Metastases
Nancy U. Lin et al.
CANCER (2008)
Chemotherapy delivery issues in central nervous system malignancy: A reality check
Leslie L. Muldoon et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases - A randomized controlled trial
Hidefumi Aoyama et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system
JS Barnholtz-Sloan et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma
LJ Schouten et al.
CANCER (2002)
Share Paper
